ABSTRACT
In a retrospective analysis of 215 patients with carbapenem-resistant
Pseudomonas aeruginosa
sepsis, we observed a significantly higher risk of mortality associated with respiratory tract infection (risk ratio [RR], 1.20; 95% confidence interval [CI], 1.04 to 1.39;
P
= 0.010) and lower risk with urinary tract infection (RR, 0.80; 95% CI, 0.71 to 0.90;
P
= 0.004). Aminoglycoside monotherapy was associated with increased mortality, even after adjusting for confounders (adjusted RR, 1.72; 95% CI, 1.03 to 2.85;
P
= 0.037), consistent across multiple sites of infection.
</jats:p
